Abiopharma

News list

Prince Joshua S. 🟢 acquired 4.4K shares of Vistagen Therapeutics, Inc. (VTGN) at $0.56 Transaction Date: Dec 31, 2025 | Filing ID: 000002

Full text

News bot Jan. 6, 2026, 1:57 a.m.
🔍 Prince Joshua S. (Executive)

Company: Vistagen Therapeutics, Inc. (VTGN)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 4,386
Detailed Transactions and Holdings:
- Acquired 4,386 shares of Common Stock at $0.5626 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,249.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).